17.ALPHA.-(3-HYDROXYPROPYL)-6.BETA.,7.BETA.,15.BETA.,16.BETA.-DIMETHYLENE-5.BETA.-ANDROSTANE-3.BETA.,5,17.BETA.-TRIOL
UNII WFD4CLB7X4

Substance Identification & Data

This profile provides standardized clinical and technical data for 17.alpha.-(3-hydroxypropyl)-6.beta.,7.beta.,15.beta.,16.beta.-dimethylene-5.beta.-androstane-3.beta.,5,17.beta.-triol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WFD4CLB7X4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 82543-18-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WFD4CLB7X4

CAS Registry Number

82543-18-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

17.ALPHA.-(3-HYDROXYPROPYL)-6.BETA.,7.BETA.,15.BETA.,16.BETA.-DIMETHYLENE-5.BETA.-ANDROSTANE-3.BETA.,5,17.BETA.-TRIOL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H38O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZDMZCRYKODGNBZ-FQKVVJEISA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

57552477

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@@]12[C@]([C@@]3([C@@]4([C@@](C4)([C@@]5(O)[C@@](C)([C@]3(CC1)[H])CC[C@H](O)C5)[H])[H])[H])([C@]6([C@](C6)([C@]2(CCCO)O)[H])[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 17.alpha.-(3-hydroxypropyl)-6.beta.,7.beta.,15.beta.,16.beta.-dimethylene-5.beta.-androstane-3.beta.,5,17.beta.-triol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(3S,5R,6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-OCTADECAHYDRO-17-(3-HYDROXYPROPYL)-10,13-DIMETHYL-5H-DICYCLOPROPA(6,7:15,16)CYCLOPENTA(A)PHENANTHRENE-3,5,17-TRIOL

SYS

17-(3-HYDROXYPROPYL)-6.BETA.,7.BETA.:15.BETA.,16.BETA.-DIMETHYLENEANDROSTANE-3.BETA.,5.BETA.,17.BETA.-TRIOL

SYS

17.ALPHA.-(3-HYDROXYPROPYL)-6.BETA.,7.BETA.,15.BETA.,16.BETA.-DIMETHYLENE-5.BETA.-ANDROSTANE-3.BETA.,5,17.BETA.-TRIOL

SYS

5H-DICYCLOPROPA(6,7:15,16)CYCLOPENTA(A)PHENANTHRENE-3,5,17-TRIOL, OCTADECAHYDRO-17-(3-HYDROXYPROPYL)-10,13-DIMETHYL-, (3S-(3.ALPHA.,5.ALPHA.,6.BETA.,7.BETA.,8.ALPHA.,9.BETA.,10.ALPHA.,13.ALPHA.,14.BETA.,15.BETA.,16.BETA.,17.ALPHA.))-

SYS

5H-DICYCLOPROPA(6,7:15,16)CYCLOPENTA(A)PHENANTHRENE-3,5,17-TRIOL, OCTADECAHYDRO-17-(3-HYDROXYPROPYL)-10,13-DIMETHYL-, (3S,5R,6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-

SYS

External Clinical & Regulatory Resources

Previous UNIIWFC7Q55HJU

Next UNIIWFD7TS6ATP